DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,104 filers reported holding DANAHER CORPORATION in Q4 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $73,074,464 | -12.4% | 292,474 | -12.5% | 0.19% | -12.7% |
Q1 2024 | $83,420,633 | +36.1% | 334,142 | +26.1% | 0.22% | +9.5% |
Q4 2023 | $61,305,243 | +48.3% | 264,999 | +59.0% | 0.20% | 0.0% |
Q3 2023 | $41,342,307 | -37.5% | 166,637 | -39.5% | 0.20% | -21.8% |
Q2 2023 | $66,111,049 | -6.3% | 275,455 | +0.2% | 0.26% | +54.8% |
Q1 2023 | $70,563,898 | -1.9% | 274,816 | +2.5% | 0.17% | -64.0% |
Q4 2022 | $71,920,921 | +185.8% | 268,038 | +175.2% | 0.46% | +52.6% |
Q3 2022 | $25,162,000 | -0.0% | 97,407 | -1.9% | 0.30% | +8.6% |
Q2 2022 | $25,170,000 | -21.2% | 99,281 | -11.1% | 0.28% | -44.0% |
Q1 2022 | $31,924,000 | -16.4% | 111,682 | -6.1% | 0.50% | -14.6% |
Q4 2021 | $38,204,000 | +15.4% | 118,969 | +9.4% | 0.58% | -20.3% |
Q3 2021 | $33,113,000 | +10.7% | 108,767 | -2.4% | 0.73% | +11.3% |
Q2 2021 | $29,914,000 | +10.3% | 111,469 | -7.5% | 0.66% | +1.7% |
Q1 2021 | $27,125,000 | +73.7% | 120,514 | +71.4% | 0.64% | +28.5% |
Q4 2020 | $15,619,000 | +2.3% | 70,313 | -0.9% | 0.50% | -20.2% |
Q3 2020 | $15,272,000 | +168.4% | 70,940 | +120.4% | 0.63% | +100.0% |
Q2 2020 | $5,691,000 | +21.1% | 32,185 | -5.2% | 0.31% | +6.1% |
Q1 2020 | $4,700,000 | -8.8% | 33,957 | +1.2% | 0.30% | +12.5% |
Q4 2019 | $5,152,000 | -26.6% | 33,567 | -30.9% | 0.26% | -36.2% |
Q3 2019 | $7,017,000 | +27.3% | 48,584 | +26.0% | 0.41% | +18.7% |
Q2 2019 | $5,511,000 | -29.3% | 38,563 | -34.7% | 0.35% | -33.9% |
Q1 2019 | $7,799,000 | -3.9% | 59,073 | -25.0% | 0.52% | -3.5% |
Q4 2018 | $8,119,000 | +2.4% | 78,730 | +7.9% | 0.54% | -0.9% |
Q3 2018 | $7,929,000 | +9.0% | 72,971 | -1.0% | 0.55% | +2.2% |
Q2 2018 | $7,273,000 | +0.8% | 73,698 | +0.0% | 0.54% | -2.7% |
Q1 2018 | $7,213,000 | -1.0% | 73,671 | -6.1% | 0.55% | +12.9% |
Q4 2017 | $7,285,000 | +6.2% | 78,483 | -1.9% | 0.49% | +0.6% |
Q3 2017 | $6,862,000 | +8.1% | 79,999 | +1.4% | 0.49% | -8.6% |
Q2 2017 | $6,346,000 | -1.5% | 78,876 | +4.7% | 0.53% | -1.1% |
Q1 2017 | $6,442,000 | +206.3% | 75,323 | +178.9% | 0.54% | -81.4% |
Q4 2016 | $2,103,000 | – | 27,011 | – | 2.89% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |